Prof. Dr. med. Pietro Vernazza
Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
Dragsted U, Lundgren J, Fox Z, Youle M, Vernazza P, Cassetti I, Hill A, Benetucci J, Bruun J, Clumeck N, Cahn P, Castagna A, Obel N, Duran A, Peters B, Pedersen C, Gerstoft J, MaxCmin1 Trial Group. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial. The Journal of infectious diseases 2003; 188:635-42.
Sep 1, 2003Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial
Sep 1, 2003The Journal of infectious diseases 2003; 188:635-42
Dragsted Ulrik Bak, Lundgren Jens D, Fox Zoe, Youle Mike, Vernazza Pietro, Cassetti Isabel, Hill Andrew, Benetucci Jorge, Bruun Johan N, Clumeck Nathan, Cahn Pedro, Castagna Antonella, Obel Niels, Duran Adriana, Peters Barry, Pedersen Court, Gerstoft Jan, MaxCmin1 Trial Group
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study
Wolf K, Bucher H, Weber R, Telenti A, Hirschel B, Bernasconi E, Furrer H, Flepp M, Vernazza P, Rickenbach M, Young J, Swiss HIV Cohort Study. Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2003; 33:494-9.
Aug 1, 2003Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study
Aug 1, 2003Journal of acquired immune deficiency syndromes (1999) 2003; 33:494-9
Wolf Katja, Bucher Heiner C, Weber Rainer, Telenti Amalio, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Flepp Markus, Vernazza Pietro, Rickenbach Martin, Young James, Swiss HIV Cohort Study
Antiretroviral therapy to reduce the sexual transmission of HIV
Taylor S, Boffito M, Vernazza P. Antiretroviral therapy to reduce the sexual transmission of HIV. Journal of HIV therapy 2003; 8:55-66.
Aug 1, 2003Antiretroviral therapy to reduce the sexual transmission of HIV
Aug 1, 2003Journal of HIV therapy 2003; 8:55-66
Taylor Stephen, Boffito Marta, Vernazza Pietro
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART
Fagard C, Hirschel B, Perrin L, Perneger T, Oxenius A, Ebnöther C, Telenti A, Bernasconi E, Vernazza P, Egger M, Hirsch H, Günthard H, Le Braz M, Swiss HIV Cohort Study. A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART. AIDS (London, England) 2003; 17:1487-92.
Jul 4, 2003A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART
Jul 4, 2003AIDS (London, England) 2003; 17:1487-92
Fagard Catherine, Hirschel Bernard, Perrin Luc, Perneger Thomas, Oxenius Annette, Ebnöther Corinna, Telenti Amalio, Bernasconi Enos, Vernazza Pietro, Egger Martin, Hirsch Hans H, Günthard Huldrych, Le Braz Michelle, Swiss HIV Cohort Study
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection
Fagard C, Price D, Dawson S, Klimkait T, Perneger T, McLean A, Clotet B, Gatell J, Perrin L, Plana M, Phillips R, Hirschel B, Yerly S, Leduc D, Oxenius A, Günthard H, Garcia F, Le Braz M, Mestre G, Battegay M, Furrer H, Vernazza P, Bernasconi E, Telenti A, Weber R, Swiss HIV Cohort Study. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. Archives of internal medicine 2003; 163:1220-6.
May 26, 2003A prospective trial of structured treatment interruptions in human immunodeficiency virus infection
May 26, 2003Archives of internal medicine 2003; 163:1220-6
Fagard Catherine, Price David, Dawson Sara J, Klimkait Thomas, Perneger Thomas V, McLean Angela, Clotet Bonaventura, Gatell Jose M, Perrin Luc, Plana Montserrat, Phillips Rodney, Hirschel Bernard, Yerly Sabine, Leduc Dominique, Oxenius Annette, Günthard Huldrych, Garcia Felipe, Le Braz Michelle, Mestre Gabriel, Battegay Manuel, Furrer Hansjakob, Vernazza Pietro, Bernasconi Enos, Telenti Amalio, Weber Rainer, Swiss HIV Cohort Study
High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner--two challenging issues
Panozzo L, Battegay M, Friedl A, Vernazza P, Swiss Cohort Study. High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner--two challenging issues. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:124-7.
Feb 22, 2003High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner--two challenging issues
Feb 22, 2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:124-7
Panozzo Laura, Battegay Manuel, Friedl Andree, Vernazza Pietro, Swiss Cohort Study
Mitochondrial DNA and sperm quality in patients under antiretroviral therapy
Diehl S, Vernazza P, Trein A, Schnaitmann E, Grimbacher B, Setzer B, Walker U. Mitochondrial DNA and sperm quality in patients under antiretroviral therapy. AIDS (London, England) 2003; 17:450-1.
Feb 14, 2003Mitochondrial DNA and sperm quality in patients under antiretroviral therapy
Feb 14, 2003AIDS (London, England) 2003; 17:450-1
Diehl Susanne, Vernazza Pietro, Trein Andreas, Schnaitmann Eiko, Grimbacher Bodo, Setzer Bernhard, Walker Ulrich A
Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland
Garbino J, Unger J, Rothen M, Dür P, Genné D, Vernazza P, Regamey C, Gerber A, Sommer R, Lew D. Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2002; 6:288-93.
Dec 1, 2002Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland
Dec 1, 2002International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2002; 6:288-93
Garbino J, Unger J P, Rothen M, Dür P, Genné D, Vernazza Pietro, Regamey C, Gerber A, Sommer R, Lew D
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study
Bucher H, Battegay M, Minder C, Vernazza P, Bernasconi E, Weber R, Hirschel B, Telenti A, Furrer H, Taffé P, Bichsel M, Swiss HIV Cohort Study. Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study. HIV medicine 2002; 3:247-53.
Oct 1, 2002Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study
Oct 1, 2002HIV medicine 2002; 3:247-53
Bucher H C, Battegay M, Minder C, Vernazza Pietro, Bernasconi E, Weber R, Hirschel B, Telenti A, Furrer H, Taffé P, Bichsel M, Swiss HIV Cohort Study
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
Greub G, Telenti A, Phillips A, Hirschel B, Günthard H, Bernasconi E, Vernazza P, Battegay M, Furrer H, Francioli P, Miller V, Perrin L, Staszewski S, Ledergerber B, Cozzi-Lepri A, Frankfurt HIV Clinic Cohort and the Swiss HIV Cohort Study. Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy. AIDS (London, England) 2002; 16:1967-9.
Sep 27, 2002Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
Sep 27, 2002AIDS (London, England) 2002; 16:1967-9
Greub Gilbert, Telenti Amalio, Phillips Andrew N, Hirschel Bernard, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Furrer Hansjakob, Francioli Patrick, Miller Veronica, Perrin Luc, Staszewski Schlomo, Ledergerber Bruno, Cozzi-Lepri Alessandro, Frankfurt HIV Clinic Cohort and the Swiss HIV Cohort Study
Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokines
Lotti B, Pichler W, Rosenberg E, Nguyen T, Wagner R, Vernazza P, Brandes M, Schnyder K, von Greyerz S, Yawalkar N, Furrer H, Wendland T, Brander C. Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokines. Journal of clinical immunology 2002; 22:253-62.
Sep 1, 2002Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokines
Sep 1, 2002Journal of clinical immunology 2002; 22:253-62
Lotti Barbara, Pichler Werner J, Rosenberg Eric, Nguyen Thi, Wagner Ralf, Vernazza Pietro, Brandes Marlène, Schnyder Karin, von Greyerz Salome, Yawalkar Nikhil, Furrer Hansjakob, Wendland Thomas, Brander Christian
Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?
Hosseinipour M, Cohen M, Vernazza P, Kashuba A. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002; 34:1391-5.
May 15, 2002Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?
May 15, 2002Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002; 34:1391-5
Hosseinipour Mina, Cohen Myron S, Vernazza Pietro, Kashuba Angela D M
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection
Opravil M, Perrin L, Weber R, Howe C, Günthard H, Ledergerber B, Battegay M, Bernasconi E, Vernazza P, Fischer M, Bisset L, Yerly S, Chave J, Furrer H, Lazzarin A, Hirschel B, Swiss HIV Cohort Study. A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection. The Journal of infectious diseases 2002; 185:1251-60.
May 1, 2002A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection
May 1, 2002The Journal of infectious diseases 2002; 185:1251-60
Opravil Milos, Perrin Luc, Weber Rainer, Howe Colin, Günthard Huldrych, Ledergerber Bruno, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Fischer Marek, Bisset Leslie R, Yerly Sabine, Chave Jean-Philippe, Furrer Hansjakob, Lazzarin Adriano, Hirschel Bernard, Swiss HIV Cohort Study
The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women
van Benthem B, Vernazza P, Coutinho R, Prins M, European Study on the Natural History of HIV Infection in Women and the Swiss HIV Cohort Study. The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. AIDS (London, England) 2002; 16:919-24.
Apr 12, 2002The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women
Apr 12, 2002AIDS (London, England) 2002; 16:919-24
van Benthem Birgit H B, Vernazza Pietro, Coutinho Roel A, Prins Maria, European Study on the Natural History of HIV Infection in Women and the Swiss HIV Cohort Study
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
Fellay J, Telenti A, Eap C, Vernazza P, Schinkel A, Ruiz L, Retelska D, Pantaleo G, Opravil M, Furrer H, Decosterd L, Chave J, Buclin T, Back D, Meaden E, Marzolini C, Swiss HIV Cohort Study. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002; 359:30-6.
Jan 5, 2002Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
Jan 5, 2002Lancet 2002; 359:30-6
Fellay Jacques, Telenti Amalio, Eap Chin B, Vernazza Pietro, Schinkel Alfred H, Ruiz Lidia, Retelska Dorota, Pantaleo Giuseppe, Opravil Milos, Furrer Hansjakob, Decosterd Laurent A, Chave Jean Philippe, Buclin Thierry, Back David J, Meaden Emma R, Marzolini Catia, Swiss HIV Cohort Study
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Phillips A, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J, Vernazza P, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA : the journal of the American Medical Association 2001; 286:2560-7.
Nov 28, 2001HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Nov 28, 2001JAMA : the journal of the American Medical Association 2001; 286:2560-7
Phillips A N, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J D, Vernazza Pietro, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance
Yerly S, Perrin L, Hirschel B, Rickenbach M, Bru J, Veuthey A, Battegay M, Telenti A, Flepp M, Vernazza P, Chave J, Rizzardi P, Vora S, Swiss HIV Cohort Study. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (London, England) 2001; 15:2287-92.
Nov 23, 2001Acute HIV infection: impact on the spread of HIV and transmission of drug resistance
Nov 23, 2001AIDS (London, England) 2001; 15:2287-92
Yerly S, Perrin L, Hirschel B, Rickenbach M, Bru J P, Veuthey A L, Battegay M, Telenti A, Flepp M, Vernazza Pietro, Chave J P, Rizzardi P, Vora S, Swiss HIV Cohort Study
Genital shedding of HIV-1 despite successful antiretroviral therapy
Vernazza P. Genital shedding of HIV-1 despite successful antiretroviral therapy. Lancet 2001; 358:1564.
Nov 10, 2001Genital shedding of HIV-1 despite successful antiretroviral therapy
Nov 10, 2001Lancet 2001; 358:1564
Vernazza Pietro
Importance of mental health assessment in HIV-infected outpatients
Zinkernagel C, Battegay M, Vernazza P, Werder V, Kiss A, Rauchfleisch U, Volkart A, Ledergerber B, Amiet R, Rickenbach M, Taffé P, Swiss HIV Cohort Study. Importance of mental health assessment in HIV-infected outpatients. Journal of acquired immune deficiency syndromes (1999) 2001; 28:240-9.
Nov 1, 2001Importance of mental health assessment in HIV-infected outpatients
Nov 1, 2001Journal of acquired immune deficiency syndromes (1999) 2001; 28:240-9
Zinkernagel C, Battegay M, Vernazza Pietro, Werder V, Kiss A, Rauchfleisch U, Volkart A C, Ledergerber B, Amiet R, Rickenbach M, Taffé P, Swiss HIV Cohort Study
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza P, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001; 358:1322-7.
Oct 20, 2001Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Oct 20, 2001Lancet 2001; 358:1322-7
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza Pietro, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study